Parabilis Medicines, Inc. carries a market capitalization of 4.71B, placing it among publicly traded companies globally.
| Market Cap | 4.71B |
| Enterprise Value | N/A |
Parabilis Medicines, Inc.'s stock has gained approximately 102.1% over the past 52 weeks. The 50-day moving average sits at 33.86, while the 200-day moving average is 32.80.
| Beta (5Y) | N/A |
| 52-Week Price Change | 102.1% |
| 50-Day Moving Average | 33.86 |
| 200-Day Moving Average | 32.80 |
| Average Volume (20 Days) | N/A |